A landmark global framework and a new treatment option have arrived simultaneously, reshaping how Australian optometrists can diagnose and manage...
Read moreDetailsResearch has found that some patients could use eye drops instead of reading glasses as they age. A retrospective study of 766...
Read moreDetailsResearchers in the US are preparing to present their findings on a “breakthrough technique” that uses electricity to mold the...
Read moreDetailsDr Leigh Plowman discusses a key drug that tackles the symptoms of dry eye disease while he tries to understand...
Read moreDetailsA new, “first-of-its kind” presbyopia drop will soon be available in the US after the Food and Drug Administration (FDA)...
Read moreDetailsPerfuse Therapeutics, Inc., a US biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases, has announced positive results from...
Read moreDetailsRayner has released its latest Peer2Peer podcast, featuring two of Australia’s most respected ophthalmic surgeons, Dr Ben LaHood and Dr...
Read moreDetailsNew data released in The Lancet Global Health by the Vision Loss Expert Group and World Health Organisation (WHO) and supported by...
Read moreDetailsLumenis BE ANZ has announced the launch of OptiPLUS in Australia and New Zealand, which the company says is the...
Read moreDetailsAt the completion of this article, the reader should be able to… • Understand the immunomodulatory role of ciclosporin in...
Read moreDetails
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited